CLINICAL_TRIALS
trial_result
· 2018-06-06
Clinical Trial Update: Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults [Phase 1]
Summary
Phase 1 study assessing the safety and tolerability of CV8102 alone and in combination with a rabies virus vaccine in healthy adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CureVac | Conditions: Rabies | Phase 1 | Status: COMPLETED